ADARx Pharmaceuticals Stock (NASDAQ:ADRX)
Previous Close
$17.63
52W Range
$16.64 - $23.21
50D Avg
$18.51
200D Avg
$18.51
Market Cap
$1.92B
Avg Vol (3M)
$871.68K
Beta
-
Div Yield
-
ADRX Company Profile
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.